BOLT vs DUK · rev $7.7M vs P/E 19, $96.46B cap
Bolt Biotherapeutics (BOLT) versus Duke Energy Corporation (DUK) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Duke Energy Corporation (DUK) is a utilities - regulated electric company listed on NYSE.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
DUK does not have a complete income-statement cache yet.
BOLT currently screens at market cap $11.3M. DUK currently screens at market cap $96.46B and trailing P/E 19.0.
Not investment advice. Open the BOLT and DUK stock pages for the full models.
Not investment advice.